Pulmonary angiogenesis is essential for alveolarization, the final stage of lung development that markedly increases gas exchange surface area. We recently demonstrated that activation of the nuclear factor kappa-B (NFjB) pathway promotes pulmonary angiogenesis during alveolarization. However, the mechanisms activating NFjB in the pulmonary endothelium, and its downstream targets are not known. In this study, we sought to delineate the specific roles for the NFjB activating kinases, IKKa and IKKb, in promoting developmental pulmonary angiogenesis. Microarray analysis of primary pulmonary endothelial cells (PECs) after silencing IKKa or IKKb demonstrated that the 2 kinases regulate unique panels of genes, with few shared targets. Although silencing IKKa induced mild impairments in angiogenic function, silencing IKKb induced more severe angiogenic defects and decreased vascular cell adhesion molecule expression, an IKKb regulated target essential for both PEC adhesion and migration. Taken together, these data show that IKKa and IKKb regulate unique genes in PEC, resulting in differential effects on angiogenesis upon inhibition, and identify IKKb as the predominant regulator of pulmonary angiogenesis during alveolarization. These data suggest that therapeutic strategies to specifically enhance IKKb activity in the pulmonary endothelium may hold promise to enhance lung growth in diseases marked by altered alveolarization.
orchestrate pulmonary angiogenesis during alveolarization remain to be elucidated.
Accumulating evidence indicates that the nuclear factor kappa B (NFjB) signalling pathway plays a key role in both physiologic and pathologic angiogenesis. The NFjB family of transcription factors consists of 5 members each able to bind DNA, and dimerize with other family members. 4 Canonical activation of NFjB occurs by phosphorylation and degradation of IjBs by the IjB kinases, IKKa and IKKb, resulting in rapid translocation of active NFjB complexes into the nucleus to regulate critical genes in cell functions. 5 NFjB enhances angiogenic sprouting during wound healing, and promotes tumour angiogenesis by increasing angiogenic molecules such as vascular endothelial growth factor (VEGF). 6, 7 Further, we recently showed that NFjB is constitutively active in the neonatal pulmonary endothelium but quiescent in the adult tissue. 8 Administration of a pharmacologic inhibitor of IKKa and IKKb disrupts alveolarization in neonatal mice, and impairs survival, proliferation and in vitro angiogenesis of primary pulmonary endothelial cells (PECs) isolated from the early alveolar lung. 8 However, the mechanisms allowing temporal-specific activation of NFjB in the pulmonary circulation during alveolarization are not known. IKKa and IKKb have structurally similar catalytic subunits, and both kinases are able to phosphorylate IjB and induce canonical activation of NFjB dimers. 9 However, IKKa and IKKb also possess 
| METHODS

| PEC isolation
Neonatal mouse (6 day old, C57BL/6) lungs were digested with collagenase IA (0.5 mg/mL) for 30 minutes at 37°C, and resulted cells were incubated with anti-CD31-coated magnetic beads (Dynabeads, Invitrogen). PECs were isolated by magnetic separation and cultivated as previously described. 8 A description of the characterization of these cells is provided in our previously published manuscript by
Iosef et al 8 , where we showed that PEC isolated by this method were found to be exclusively CD45(À) and greater than 95% CD31
(+)/CD102(+) by flow cytometry. 12 Comparisons between groups and Meta-Analysis were performed, revealing common and differential gene expression in the 3 groups of PEC.
| RNA interference
| Quantitative real-time PCR (qRT-PCR)
Total RNA was isolated from PEC and whole mouse lung using the RNeasy kit (Qiagen). RNA (2 lg) was reverse-transcribed using Superscript III (Invitrogen), and qPCR was performed using TaqMan primers (Applied Biosystems) as described previously. 13 Quantification of target gene expression was performed using the standard curve method and normalizing to the expression of either 18s or b2M which were both stable in our transfected cells through experiments performed over several years. 
| Apoptosis assays
At 24 hours post-transfection, cells were transferred to 96-well plates (1 9 10 4 cells/well) and after reaching 80%-90% confluence, the media was exchanged for starvation media (FBS 0.2% without additional growth factors). Separate groups of cells were exposed to TNFa (20 ng/mL) to induce apoptosis for 4, 8 and 24 hours. Apoptosis was measured by determining the amount of active caspase 3/7 using a Luciferase-Glo system (Promega). The assays were carried out per manufacturer's protocol, and the luciferase reactions read using a
Berthold LG&G Lumat LG luminometer as performed previously. 
| Western blot
Whole cell lysates were obtained from PEC using a lysis buffer containing 10 mmol/L Tris-HCl and 1% SDS, heated to 100°C. Protein lysates were subjected to SDS-PAGE. Membranes were incubated with primary antibodies to detect Akt, pAKT, p38, ERK1/2 (Cell Signaling), tubulin (Abcam), IKKa and IKKb (Cell Signaling) and the appropriate HRP-conjugated secondary antibody, followed by enhanced chemiluminescence detection (GE Life Sciences).
| Wound healing assay
At 24 hours post-siRNA transfection, PECs were plated on BD-Falcon culture slides coated with 0.2% gelatine. Once confluent, the monolayer was wounded with a fine pipette-tip creating a wound along the diagonal axis of the well. The wound was permitted to heal by PEC migration for the next 24 hours. Phase contrast images were captured before and after the healing process using a Nikon Eclipse inverted microscope with NIS Elements software. The wound closure area was analysed using Image-J software. 
| F-Actin cytochemistry
| Silencing IKKb impairs PEC proliferation in response to selected growth factors
Analyses of the genes differentially regulated by the IKKs revealed multiple factors important in cell cycle checkpoints and proliferation which were altered by silencing IKKa, including cyclin D1 (CCND1), 14 the transcription factor E2F3 15 and Akt3. 16 In contrast, fewer genes relevant to proliferation appeared dysregulated by IKKb silencing but included up-regulation of Flt1, a molecule able to antagonize VEGFmediated angiogenic function. 17 To 
| Silencing IKKa or IKKb impairs PEC survival
The NFjB/IKK signalling pathway can have divergent effects on cell survival, inducing either pro-or anti-apoptotic targets. 18, 19 Our prior work demonstrated that simultaneous inhibition of both IKKs with a pharmacologic inhibitor rapidly induces apoptosis in the neonatal PEC. 8 To 
| Silencing IKKa and IKKb induce distinct abnormalities in cell adhesion and motility
In addition to proliferation and survival, effective angiogenesis requires coordinated steps of cell motility, including the attachment of cellular protrusions to the extracellular matrix. 21 Thus, we next evaluated the roles of IKKa and IKKb on mediating cell adhesion to 3 matrices: gelatine, type II collagen and fibronectin. NTC-cells adhered best to collagen ( Figure 4B ), and least effectively to gelatine ( Figure 4A ). Loss of IKKa disrupted cell adhesion to both collagen and gelatine, but adhesion to fibronectin ( Figure 4C ) was preserved.
In contradistinction, loss of IKKb impaired adhesion to all 3 matrices, although adhesion to gelatine was less affected than that observed after the loss of IKKa.
We also evaluated the impact of silencing IKKa, and IKKb on PEC migration by wound-healing assays in the NTC, IKKa and IKKb siRNA-treated neonatal PEC. 22 NTC-PECs at the leading edge of the 
| Silencing IKKa and IKKb causes distinct defects in actin cytoskeletal rearrangement
Cell migration requires coordinated changes in the remodelling of the actin cytoskeleton to form filopodia, lamellipodia and stress fibres. 21 We next evaluated the effect of silencing either IKKa or IKKb on cytoskeletal remodelling at baseline, and in response to growth factor stimulation. There were no obvious differences in the actin cytoskeleton in the NTC, IKKa and IKKb siRNA-treated PEC under short-term starvation conditions of 12 hours ( Figure 5 ). We chose to starve the cells for a short term to avoid any apoptosis implication in the process.
In all 3 groups, cortical actin was prominent, with the absence of stress Representative Western blots to detect phosphorylated and total p38 (A), Akt (B) and ERK (C) 5 min after stimulation with starvation media (0.2% FBS), EGM, or starvation media containing VEGF (50 ng/mL). Data shown are the mean AE SEM of n = 3 immunoblots, with the amount of protein in each band expressed as the fold change over the NTC starvation sample. *P < .05, **P < .01 and ****P < .0001 vs starvation
| IKKb mediated regulation of VCAM serves to promote PEC adhesion and migration
We next sought to identify downstream effector molecules regulated by the NFjB pathway that were promoting angiogenesis in the PEC. Figure 7E ). NTC siRNA-treated PEC located at the leading edge of the wound were organized in parallel, with some cells extending lamellipodia towards the direction of the scratch. In contrast, the VCAM siRNA-treated PEC at the wound edge were disorganized, with many cells extending abnormally long, thin filopodia in multiple directions ( Figure 7E ).
To qualify these defects in migration, we compared the effects of silencing VCAM with those induced by silencing IKKb ( Figure 7F ) in a wound healing assay. Although the NTC siRNA-treated PEC were able to effectively close the wound in the monolayer, similar impairments in wound healing were observed in response to silencing both IKKb and VCAM. Similarly, using a method to assess VEGF-mediated tube formation, we found that both IKKb and VCAM siRNA-treated PEC developed an overall decrease in the total length of tube formation, and a decreased number of branch points as compared to the NTC siRNA-treated PEC ( Figure 7G ).
| DISCUSSION
We previously identified the NFjB as an essential regulator of pulmonary angiogenesis during postnatal lung growth and alveolarization. 8, 13 Here we report independent functions for IKKa and IKKb in the developing pulmonary circulation, with IKKb as the predominant regulator of angiogenesis during alveolarization.
In the canonical pathway of NFjB activation, IKKa and IKKb work in concert to release NFjB dimers from the inhibitory IjBs, and allow their translocation to the nucleus to regulate gene expression. Our prior studies found that NFjB is endogenously active in neonatal PECs during early alveolarization, but the mechanism allowing for this developmental activation is not yet clear. Constitutive activity of NFjB is normally restricted to cells from the hematopoietic lineage. 25 In other cell types, basal NFjB activity is negligible and induced only after stimulation. 26 However, high levels of constitutively active NFkB are found in cancer cells, induced by paracrine secretion of cytokines and other factors from the tumour. 27 Therefore, it is possible that secreted factors present in the lung microenvironment allow for temporal-specific activation of the IKKb/NFjB pathway in the developing pulmonary endothelium.
Despite significant sequence homology, silencing IKKa and IKKb in PEC resulted in the dysregulation of both shared and unique genes. Both IKKa and IKKb can exert distinct NFjB-dependent and independent effects that vary in a cell stimulus-specific manner. 10 and increased IKKb has been noted in multiple tumour types. 37 In both cancer and wound healing, the pro-angiogenic effects of the IKK/NFjB pathway have primarily been attributed to the transcriptional regulation of pro-angiogenic cytokines and growth factors. 6, 38 In contrast, in both here and in our prior study, we show that IKKa and IKKb have direct effects on PECs, controlling angiogenesis.
In our study, silencing either IKKa or IKKb impaired PEC survival.
Anti-apoptotic functions of the IKK/NFjB pathway have been well described. Deletions of either IKKb or the NFjB subunit RelA result in early embryonic lethality as a result of extensive liver apoptosis. 28 In macrophages, loss of IKKa compromises survival by decreasing
Akt phosphorylation. 39 Numerous anti-apoptotic genes are under transcriptional control of the NFjB pathway, including BCL-2 families. 40 NFjB also regulates apoptosis by influencing p53 stability. 41 IKKa too has a separate anti-apoptotic function, influencing the ability of CBP to bind to either p53 or RelA, thus regulating the balance between pro-survival, NFjB signalling and pro-apoptotic p53 signalling. 41, 42 We found that IKKb was clearly the predominant regulator of angiogenesis with more profound defects in proliferation, adhesion, migration and cytoskeletal remodelling. In the IKKb depleted cells, proliferation was impaired in response to EGM, VEGF and FGF-2.
Both VEGF and FGF-2 are important growth factors that regulate angiogenesis during development and disease. 43, 44 Interestingly, the IKKb depleted cells demonstrated a non-significant trend in increased cell proliferation in response to IGF-1, IGF-1 is expressed in blood vessels of neonatal but not adult animals, and expression is increased in budding capillaries. 45 Blocking the IGF-1 receptor in human and rat foetal lung explants induces endothelial cell loss, increases mesenchymal cell apoptosis and disrupts lung development. 46 This suggests that in the absence of effective VEGF or FGF-2 signalling, compensatory mechanisms through IGF axis may be invoked in the IKKb depleted cells to preserve proliferation.
Vascular endothelial growth factor signalling through the VEGFR2 receptor is an essential pathway mediating postnatal pulmonary angiogenesis during alveolarization. 47, 48 VEGF is decreased in the lungs of premature infants dying from BPD and in the lungs of animal models of disrupted alveolarization and pulmonary angiogenesis. 3, [49] [50] [51] Blocking VEGF/VEGFR2 signalling in neonatal rats decreases pulmonary arterial density and impairs alveolarization, 52 while overexpression of VEGF in newborn rats exposed to hyperoxia preserves pulmonary angiogenesis and alveolarization and increases survival. 53 Loss of IKKb appeared to result in specific defects in There are a number of limitations to our study. First, given that the loss of both IKKa and IKKb also induced impairments in cell survival it is impossible to fully separate the effects of cell death on other measures of angiogic function, including adhesion, migration and in vitro angiogenesis. However, the greater degree of cell death was observed in response to TNF-a stimulation, or in response to prolonged serum starvation. In attempt to limit these confounders as much as possible, we performed these function assays with either no or short periods of starvation, and with assay times that were also short in nature. Second, although our prior work demonstrated that pharmacologic inhibition of both IKKa and IKKb effectively impairs pulmonary angiogenesis and disrupts alveolarizartion in neonatal mice in vivo, 8 definitive evidence for a role for IKKb in promoting pulmonary angiogenesis in vivo using an inducible, cell-specific model allowing EC-specific deletion at the start of alveolarization has not been done.
In summary, we explored the specific roles of IKKa and IKKb in the developing pulmonary endothelium. Silencing either IKKa and IKKb disrupted hundreds of genes, but the panels of genes regulated by the 2 kinases were distinct, suggesting that each kinase has separate func- Disrupted angiogenesis contributes to many paediatric diseases, including bronchopulmonary dysplasia, and therapeutic strategies to enhance angiogenesis may have potential benefit to these and other lung diseases marked by impaired angiogenesis. Our prior study showed that disrupting IKK-mediated signalling disrupts both angiogenesis and alveolarization. Data from this study identify IKKb as the predominant regulator of angiogenic function in developing pulmonary endothelial cells and suggest that strategies aimed to specifically preserve and enhance IKKb activity may be an important therapeutic strategy to preserve late lung growth.
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